Mitsubishi UFJ Trust & Banking Corp Has $16.24 Million Position in Solventum Co. (NYSE:SOLV)

Mitsubishi UFJ Trust & Banking Corp boosted its holdings in shares of Solventum Co. (NYSE:SOLV) by 3.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 245,800 shares of the company’s stock after buying an additional 7,758 shares during the period. Mitsubishi UFJ Trust & Banking Corp owned approximately 0.14% of Solventum worth $16,238,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the business. New York Life Investment Management LLC raised its holdings in shares of Solventum by 0.7% in the 4th quarter. New York Life Investment Management LLC now owns 18,506 shares of the company’s stock worth $1,223,000 after acquiring an additional 136 shares during the last quarter. Blue Trust Inc. increased its holdings in Solventum by 2.1% during the 4th quarter. Blue Trust Inc. now owns 7,872 shares of the company’s stock worth $549,000 after purchasing an additional 161 shares in the last quarter. MML Investors Services LLC raised its stake in shares of Solventum by 3.2% in the third quarter. MML Investors Services LLC now owns 5,345 shares of the company’s stock worth $373,000 after purchasing an additional 168 shares during the last quarter. Avantax Advisory Services Inc. lifted its holdings in shares of Solventum by 2.2% in the fourth quarter. Avantax Advisory Services Inc. now owns 8,835 shares of the company’s stock valued at $584,000 after purchasing an additional 192 shares in the last quarter. Finally, EverSource Wealth Advisors LLC boosted its position in shares of Solventum by 48.1% during the fourth quarter. EverSource Wealth Advisors LLC now owns 687 shares of the company’s stock valued at $45,000 after buying an additional 223 shares during the last quarter.

Solventum Stock Down 1.0 %

Shares of NYSE SOLV opened at $74.78 on Friday. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. The stock has a market capitalization of $12.94 billion and a PE ratio of 27.19. Solventum Co. has a one year low of $47.16 and a one year high of $85.92. The business’s fifty day moving average price is $75.51 and its 200-day moving average price is $71.83.

Wall Street Analyst Weigh In

SOLV has been the topic of several recent analyst reports. Bank of America raised their price objective on Solventum from $80.00 to $85.00 and gave the company a “neutral” rating in a research note on Wednesday, February 26th. The Goldman Sachs Group boosted their price target on shares of Solventum from $63.00 to $71.00 and gave the stock a “sell” rating in a report on Monday, March 3rd. Wells Fargo & Company increased their price objective on shares of Solventum from $73.00 to $75.00 and gave the company an “equal weight” rating in a research note on Friday, February 28th. Piper Sandler boosted their target price on Solventum from $75.00 to $84.00 and gave the stock a “neutral” rating in a research note on Friday, February 28th. Finally, Mizuho increased their price target on Solventum from $70.00 to $82.00 and gave the company a “neutral” rating in a research report on Monday, March 3rd. One analyst has rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $79.86.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.